Clinical trials
Pre-Eclampsia, Severe clinical trials
Below are recruiting pre-eclampsia, severe clinical trials, each written for real people, not researchers. We’re tracking 12 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05746793Recruiting
IVF pregnancy study to prevent pre-eclampsia in high-risk women
This trial studies ways to lower the risk of pre-eclampsia (dangerous high blood pressure in pregnancy) in women who are having a first pregnancy through IVF/ICSI or who have PCOS. It’s aimed at people considered higher risk for pre-eclampsia.
BrusselsAges 18–48 - NCT06785116RecruitingPhase 4
Study on dapagliflozin for heart health after a hypertensive pregnancy
This trial tests a medicine called dapagliflozin (DAPA) to see if it reduces heart risk in women who had high blood pressure or preeclampsia during pregnancy. It is designed for those who had severe blood pressure rises around delivery or a high BNP level, a marker of heart strain.
Ann Arbor, MichiganAges 18 years+ - NCT07263490Recruiting
Pre-eclampsia Risk in Egg Recipients Study
This study looks at whether women who become pregnant after receiving donated eggs have a higher risk of developing pre-eclampsia (a serious blood pressure condition) during pregnancy. It aims to understand risks so doctors can better support pregnant women.
CopenhagenAges 18 years+ - NCT05675969Recruiting
Testing tiny blood particles in at-risk early delivery
This pilot study looks at tiny particles in blood (microvesicles) to learn how they differ in women with threatened preterm delivery, with or without pre-eclampsia. Results may help doctors better identify risk and improve care for early delivery.
BordeauxAges 18 years+ - NCT03806283Recruiting
Study how pregnancy blood vessels change in late pregnancy
This study looks at how blood vessels adapt during late pregnancy, especially around the time of a C-section. Your participation may help researchers understand normal pregnancy changes and how they differ in certain complications.
Madison, WisconsinAges 18–40 - NCT04356326RecruitingPhase 3
Aspirin to prevent complications in pregnancy with chronic high blood pressure
This trial studies whether taking acetyl salicylic acid (aspirin) during pregnancy can reduce problems caused by chronic high blood pressure. It focuses on pregnant people already known to have high blood pressure before or early in pregnancy.
BordeauxAges 18 years+ - NCT05434195Recruiting
Study folate in pregnancies with high blood pressure
This study looks at how a vitamin called tetrahydrofolate may affect pregnancies with preeclampsia or increased risk of high blood pressure. Participants may receive the supplement to help researchers understand key biology and potential benefits or harms.
Oxford, OxfordhsireAges 18–45 - NCT06408181RecruitingPhase 3
Aspirin to prevent pregnancy loss and preeclampsia
This study tests whether taking a daily low-dose aspirin can help prevent pregnancy loss and preeclampsia. It's for women who are in early pregnancy and have certain health risks.
Philadelphia, PennsylvaniaAges 18–45 - NCT06539026Recruiting
Fluid therapy guided by vein ultrasound in preeclampsia
This trial is testing a way to give fluids before C-section to women with severe preeclampsia. It uses an ultrasound measure of the big vein in your belly (the inferior vena cava) to help decide how much fluid is safe, which may reduce complications.
Cairo, EgyptAges Any age - NCT06821685RecruitingPhase 1
Natural killer cell therapy for infertility and pregnancy problems
This study tests a treatment using your own immune cells (natural killer cells) to improve pregnancy chances. It's for women with infertility, repeated miscarriages, or other pregnancy complications linked to abnormal natural killer cell function.
Nanjing, JiangsuAges 22–40 - NCT07245056Recruiting
Fetal brain study in early-onset preeclampsia
This study uses ultrasound to examine specific parts of the fetal brain (the fornix and hippocampus) in pregnant women diagnosed with early-onset preeclampsia. It aims to understand how this condition might affect brain development before birth.
Ankara, YenimahalleAges 18–45 - NCT04762992Enrolling by invitationPhase 3
Heparin medicine for early slow fetal growth in one pregnancy
This study tests whether a blood-thinner medicine (LMWH) can improve outcomes for people carrying a singleton baby with early signs of slow growth. It compares LMWH against standard care to see if treatment helps the baby and pregnancy stay safer.
LisbonAges 18 years+
Hear when a new Pre-Eclampsia, Severe trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pre-eclampsia, severe?
- Yes. Clin2 currently lists 12 recruiting pre-eclampsia, severe studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pre-eclampsia, severe trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pre-eclampsia, severe trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.